Literature DB >> 17264819

Predominant infiltration of monocytes in chronic graft-versus-host disease.

Noriko Namba1, Katsuji Shinagawa, Nobuharu Fujii, Yoshinobu Maeda, Fumihiko Ishimaru, Kazuma Ikeda, Toshimitsu Matsui, Mitsune Tanimoto, Yoshio Katayama.   

Abstract

Pathogenesis of chronic graft-versus-host disease (cGVHD) is largely unknown. It is important to determine the responsible cell types and the factors that play roles to recruit these cells into sites of disease. We examined whether monocytes and chemokine fractalkine/receptor CX3CR1 axis might be involved. We found that the absolute number of CX3CR1+ monocytes in the blood was significantly decreased in patients with severe cGVHD. Immunohistochemical staining revealed the extensive infiltration of CD14+ cells as well as strong expression of fractalkine in the cGVHD skin. The number of infiltrated CD14+ cells on the margin of fractalkine+ epidermis was larger in cGVHD skin compared to that of acute graft-versus-host disease, whereas no difference was observed in CD3+ T cells. These results suggest that CX3CR1+ monocytes may be recruited from the circulation to the fractalkine+ epidermis in cGVHD, and highlight these cells and this chemokine/receptor axis as additional targets for cGVHD therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17264819     DOI: 10.1097/01.tp.0000245080.71722.87

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  6 in total

1.  Interleukin-10 spot-forming cells as a novel biomarker of chronic graft-versus-host disease.

Authors:  Masahiro Hirayama; Eiichi Azuma; Atsuko Nakagawa-Nakazawa; Tadashi Kumamoto; Shotaro Iwamoto; Keishiro Amano; Shigehisa Tamaki; Eiji Usui; Yoshihiro Komada
Journal:  Haematologica       Date:  2012-06-24       Impact factor: 9.941

2.  Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease.

Authors:  Frances T Hakim; Sarfraz Memon; Ping Jin; Matin M Imanguli; Huan Wang; Najibah Rehman; Xiao-Yi Yan; Jeremy Rose; Jacqueline W Mays; Susan Dhamala; Veena Kapoor; William Telford; John Dickinson; Sean Davis; David Halverson; Haley B Naik; Kristin Baird; Daniel Fowler; David Stroncek; Edward W Cowen; Steven Z Pavletic; Ronald E Gress
Journal:  J Immunol       Date:  2016-09-30       Impact factor: 5.422

3.  Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantation.

Authors:  Daigo Hashimoto; Andrew Chow; Melanie Greter; Yvonne Saenger; Wing-Hong Kwan; Marylene Leboeuf; Florent Ginhoux; Jordi C Ochando; Yuya Kunisaki; Nico van Rooijen; Chen Liu; Takanori Teshima; Peter S Heeger; E Richard Stanley; Paul S Frenette; Miriam Merad
Journal:  J Exp Med       Date:  2011-05-02       Impact factor: 14.307

4.  Rhinosinusitis in hematopoietic stem cell-transplanted patients: influence of nasosinus mucosal abnormalities?

Authors:  Erica Ortiz; Albina Altemani; Afonso Celso Vigorito; Eulalia Sakano; Ester Maria Danielli Nicola
Journal:  Stem Cell Res Ther       Date:  2014-12-04       Impact factor: 6.832

5.  High frequency of CD29high intermediate monocytes correlates with the activity of chronic graft-versus-host disease.

Authors:  Masahiro Hirayama; Eiichi Azuma; Shotaro Iwamoto; Keishiro Amano; Atsuko Nakazawa; Shigehisa Tamaki; Eiji Usui; Yoshihiro Komada
Journal:  Eur J Haematol       Date:  2013-07-12       Impact factor: 3.674

6.  National Institutes of Health-Defined Chronic Graft-vs.-Host Disease in Pediatric Hematopoietic Stem Cell Transplantation Patients Correlates With Parameters of Long-Term Immune Reconstitution.

Authors:  Anita Lawitschka; Ece Dila Gueclue; Angela Januszko; Ulrike Körmöczi; Arno Rottal; Gerhard Fritsch; Dorothea Bauer; Christina Peters; Hildegard T Greinix; Winfried F Pickl; Zoya Kuzmina
Journal:  Front Immunol       Date:  2019-08-27       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.